Clover Corporation (CLV) H2 2025 earnings summary

Executive summary

• Achieved record FY25 revenue of $86.0 million, up 38% year-over-year, with strong growth across all metrics and a significant increase in NPAT to $7.0 million from $1.5 million.

• Strong second-half performance, with revenue of $48.4 million versus $37.6 million in the first half, and a record final quarter driven by seasonal demand.

• Expanded product portfolio and customer base, with growth in Asia and Europe, supported by new distributors and product launches.

• Declared a final dividend of $0.01 per share for FY25.

• Significant operational improvements and debt reduction achieved.

Financial highlights

• EBITDA for FY25 was $12.1 million, up from $3.9 million year-over-year.

• Gross margin improved by 3 percentage points to 33%, up from 29% year-over-year, driven by innovative products.

• Cash from operating activities was $8.3 million, with cash position at $8.7 million and significant debt reduction to $0.9 million.

• Inventory at year-end was $24.1 million, with expectations to increase toward $30 million.

• EPS improved to 4.20c from 0.87c, and ROE annualized at 9.8% versus 2.3% prior year.

Outlook and guidance

• Revenue for 1H FY26 expected to be in line with 1H FY25, reflecting flat customer demand and stable market conditions.

• Anticipates traditional seasonality with a stronger second half and growth expected to return in 2H FY26, dependent on customer orders.

• Gross margins expected to remain consistent or marginally improve, supported by increased Ecuador facility output.

• Operating expenses projected to grow at a low single-digit rate, mainly due to wage growth and increased resourcing.

• Strategy focuses on accelerating new product commercialization and expanding into high-growth segments.